Intellia Therapeutics Inc (NASDAQ: NTLA)’s stock price has gone decline by -1.42 in comparison to its previous close of 21.81, however, the company has experienced
The stock of Intellia Therapeutics Inc (NTLA) has gone down by -0.62% for the week, with a -15.96% drop in the past month and a
The stock of Intellia Therapeutics Inc (NTLA) has gone down by -6.45% for the week, with a -23.15% drop in the past month and a
Additionally, the 36-month beta value for NTLA is 1.78. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 3
© 2024, Fueled by Smart TechOne
